The present invention provides combinations of a DNA topoisomerase I inhibiting agent and a selective COX-2 inhibiting agent for preventing, treating, and/or reducing the risk of developing a neoplasia disorder in a mammal.
本发明提供了一种
DNA拓扑异构酶I抑制剂和选择性COX-2
抑制剂的组合物,用于预防、治疗和/或减少哺乳动物发生肿瘤性疾病的风险。